DICER1 and DICER1-related tumor predisposition: DICER1 syndrome, first characterised in 2009 and recognised in the 2022 WHO classification, is defined as an ‘autosomal dominant tumour predisposition syndrome caused by heterozygous germline pathogenic variants in DICER1’ (1).